Psoriasis classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 53: Line 53:
* Mild (affecting less than 3% of the body)  
* Mild (affecting less than 3% of the body)  
* Moderate (affecting 3-10% of the body)   
* Moderate (affecting 3-10% of the body)   
* Severe.  
* Severe   
** Several scales exist for measuring the severity of psoriasis.  
Several scales exist for measuring the severity of psoriasis.  
The degree of severity is generally based on the following factors: the proportion of body surface area affected; disease activity (degree of plaque redness, thickness and scaling); response to previous therapies; and the impact of the disease on the person.  
The degree of severity is generally based on the following factors:  
 
*The proportion of body surface area affected
*Disease activity (degree of plaque redness, thickness and scaling)  
*Response to previous therapies
*The impact of the disease on the person.  
===Psoriasis Area Severity Index (PASI)===
The Psoriasis Area Severity Index (PASI) is the most widely used measurement tool for psoriasis. PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease).<ref>{{cite web |url=http://www.skinandaging.com/article/5394 |title=Psoriasis Update -Skin & Aging |accessdate=2007-07-28 |format= |work=}}</ref>  
The Psoriasis Area Severity Index (PASI) is the most widely used measurement tool for psoriasis. PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease).<ref>{{cite web |url=http://www.skinandaging.com/article/5394 |title=Psoriasis Update -Skin & Aging |accessdate=2007-07-28 |format= |work=}}</ref>  
 
The PASI can be too unwieldy to use outside of trials, which has led to attempts to simplify the index for clinical use.<ref name="pmid15530297">{{cite journal |author=Louden BA, Pearce DJ, Lang W, Feldman SR |title=A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients |journal=Dermatol. Online J. |volume=10 |issue=2 |pages=7 |year=2004 |pmid=15530297 |doi=}}</ref>
Nevertheless, the PASI can be too unwieldy to use outside of trials, which has led to attempts to simplify the index for clinical use.<ref name="pmid15530297">{{cite journal |author=Louden BA, Pearce DJ, Lang W, Feldman SR |title=A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients |journal=Dermatol. Online J. |volume=10 |issue=2 |pages=7 |year=2004 |pmid=15530297 |doi=}}</ref>





Revision as of 14:08, 21 June 2017

Psoriasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Psoriasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT scan

MRI

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Psoriasis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Psoriasis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Psoriasis classification

CDC on Psoriasis classification

Psoriasis classification in the news

Blogs on Psoriasis classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Psoriasis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Classification

Psoriasis can be classified according to clinical appearence, morphology and localization.

  • The International Psoriasis Council, identifies four main forms of psoriasis:
    • Plaque-type psoriasis
    • Guttate psoriasis
    • Generalized Pustular Psoriasis (GPP)
    • Erythroderma

Several further subphenotypes have been named according to distribution (localized vs. widespread), anatomical localization (flexural- also called inverse, scalp, palms/soles/nail), size (large vs. small) and thickness (thick vs. thin) of plaques, onset (early vs. late), and disease activity (active vs. stable).

Plaque-type Psoriasis

  • Plaque-type psoriasis is the most common form of psoriasis affecting patients.
  • It is characterized by oval or irregularly shaped, red, sharply demarcated, raised plaques covered by silvery scales.
  • Plaques occur usually on the extensor surface of elbows and knees, on the scalp, and on the lower back, but can affect almost any area of the body.
  • Large plaques are >3cm in size and small scales are <3cm is size.

Guttate Psoriasis

  • Guttate psoriasis is characterized by multiple, small, drop-shaped, scaly plaques usually occurring around the trunk and upper extremities and thighs.
  • It is sudden onset, usually occurs within 2–4 wk after a bacterial infection of the upper ways, notably streptococcal pharyngitis in children and adolescents.
  • Lesions can either resolve spontaneously or progress to plaque-type psoriasis.

Generalized pustular psoriasis

Erythrodermic Psoriasis

  • Erythromdermic psoriasis is the rarest form of psoriasis but is the severest form.
  • It is characterized by diffuse erythema which includes greater than seventy percent of the human body.
  • Systemic manifestations such as hypothermia and extremity edema might be present because of the generalized vasodilation underlying the erythema, as well as myalgiafatigue and fever.

Other types of psoriasis

  • Flexural psoriasis (inverse psoriasis) appears as smooth inflamed patches of skin. It occurs in skin folds, particularly around the genitals (between the thigh and groin), axillae, under an overweight stomach (pannus), and under the breasts (inframammary fold). It is aggravated by friction and sweat, and is vulnerable to fungal infections.
  • Nail psoriasis produces a variety of changes in the appearance of finger and toe nails. These changes include discolouring under the nail plate, pitting of the nails, lines going across the nails, thickening of the skin under the nail, and the loosening (onycholysis) and crumbling of the nail.
  • Drug-induced psoriasis
  • Napkin psoriasis
  • Seborrheic-like psoriasis
  • Pustular psoriasis

Severity

Pie chart showing the distribution of severity among people with psoriasis.

Psoriasis is usually graded as:

  • Mild (affecting less than 3% of the body)
  • Moderate (affecting 3-10% of the body)
  • Severe

Several scales exist for measuring the severity of psoriasis. The degree of severity is generally based on the following factors:

  • The proportion of body surface area affected
  • Disease activity (degree of plaque redness, thickness and scaling)
  • Response to previous therapies
  • The impact of the disease on the person.

Psoriasis Area Severity Index (PASI)

The Psoriasis Area Severity Index (PASI) is the most widely used measurement tool for psoriasis. PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease).[1] The PASI can be too unwieldy to use outside of trials, which has led to attempts to simplify the index for clinical use.[2]


References

  1. "Psoriasis Update -Skin & Aging". Retrieved 2007-07-28.
  2. Louden BA, Pearce DJ, Lang W, Feldman SR (2004). "A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients". Dermatol. Online J. 10 (2): 7. PMID 15530297.

Template:WH Template:WS